NEXIEN BIOPHARMA, INC. Shareholders' Equity
NEXIEN BIOPHARMA, INC. had Shareholders' Equity of -$450.52 thousand as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-05-14
- 2025-03-31: Stockholders' Equity Attributable to Parent -$450.52K.
- 2024-12-31: Stockholders' Equity Attributable to Parent -$422.69K.
- 2024-09-30: Stockholders' Equity Attributable to Parent -$391.75K.
- 2024-06-30: Stockholders' Equity Attributable to Parent -$361.25K.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-03-31 | -$450.52K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$422.69K 10-Q · filed 2025-05-14 | |
| 2024-09-30 | -$391.75K 10-Q · filed 2025-05-14 | |
| 2024-06-30 | -$361.25K 10-Q · filed 2025-05-14 | |
| 2024-03-31 | -$325.29K 10-Q · filed 2025-05-14 | |
| 2023-12-31 | -$314.19K 10-Q · filed 2025-05-14 | |
| 2023-09-30 | -$290.80K 10-Q · filed 2025-05-14 | |
| 2023-06-30 | -$252.01K 10-Q · filed 2025-05-14 | |
| 2023-03-31 | -$230.30K 10-Q · filed 2024-05-15 | |
| 2022-12-31 | -$202.32K 10-Q · filed 2024-05-15 | |
| 2022-09-30 | -$160.60K 10-Q · filed 2024-05-15 | |
| 2022-06-30 | -$117.61K 10-K · filed 2024-10-22 | |
| 2022-03-31 | -$63.26K 10-Q · filed 2023-05-17 | |
| 2021-12-31 | -$62.42K 10-Q · filed 2023-05-17 | |
| 2021-09-30 | -$39.99K 10-Q · filed 2023-05-17 | |
| 2021-06-30 | -$13.78K 10-K · filed 2023-09-28 | |
| 2021-03-31 | $20.81K 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $23.56K 10-Q · filed 2022-02-08 | $23.75K 10-Q · filed 2021-02-11 |
| 2020-09-30 | -$7.48K 10-Q · filed 2021-11-22 | |
| 2020-06-30 | -$6.37K 10-K · filed 2022-09-28 | |
| 2020-03-31 | $94.75K 10-Q · filed 2021-05-05 | |
| 2019-12-31 | $128.34K 10-Q · filed 2021-02-11 | |
| 2019-09-30 | $183.56K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $265.92K 10-K · filed 2021-10-12 | |
| 2019-03-31 | $748.46K 10-Q · filed 2020-05-14 | |
| 2018-12-31 | $845.13K 10-Q · filed 2020-02-12 | |
| 2018-09-30 | $973.69K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $1.18M 10-K · filed 2020-09-28 | |
| 2018-03-31 | $1.13M 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $1.11M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | -$106.11K 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $563.29K 10-K · filed 2019-09-30 | -$91.58K 10-K · filed 2017-07-31 |
| 2017-03-31 | -$86.67K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | -$81.40K 10-Q · filed 2017-02-06 | |
| 2016-09-30 | -$76.61K 10-Q · filed 2016-10-19 | |
| 2016-06-30 | -$69.90K 10-K · filed 2017-07-31 | |
| 2016-03-31 | -$65.12K 10-Q · filed 2016-04-13 | |
| 2015-12-31 | -$59.88K 10-Q · filed 2016-02-04 | |
| 2015-09-30 | -$55.40K 10-Q · filed 2015-10-14 | |
| 2015-06-30 | -$48.91K 10-K · filed 2016-09-28 | |
| 2015-03-31 | -$44.68K 10-Q · filed 2015-05-06 | |
| 2014-12-31 | -$40.82K 10-Q · filed 2015-02-13 | |
| 2014-06-30 | -$484.00 10-K · filed 2015-09-15 |